Share This

Public company info - Hospital Corporation of China Limited , 03869.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Hospital Corporation of China Limited, 03869.HK - Company Profile
Chairman CHEN Shuai
Share Issued (share) 138,000,000
Par Currency Hong Kong Dollar
Par Value 0.001
Industry Medical Equipment & Services
Corporate Profile Business Summary: The Group are principally engaged in (i) operation and management of its privately owned hospital; (ii) provision of management and consultation services to three not-for-profit hospitals and (iii) wholesale of pharmaceutical products in the People’s Republic of China (the ‘PRC’). Performance for the year: The Group’s revenue increased by 7.1% from RMB383.6 million in 2018 to RMB410.9 million in 2019. Business Review： Main businesses: During the year under review, in accordance with the requirements of the Board of Directors and arrangements under the “Annual Business Plan (《年度商業計劃》)”, the Group actively promoted activities such as investment, M&A, operation and management, expansion of new business models and governance as a listed company, and achieved excellent results. In particular, under the leadership of the Board of Directors, the Group’s business teams and core teams were united with a proactive attitude and were in good condition. In addition, the concepts of “successful acquisition, well management, scale expansion (收到、管好、上量)” and “building a value-creating medical group under the “Three Conforming” conditions (打造“三符合”價值創 造型醫療集團)” were widely understood and accepted by the Group and the Group Hospitals. The development direction, working ideas and strategies of the Group became clearer through abundant practice, re-examination and systematic organization. The Group’s main leaders visited frontline hospitals to explore their development model and summarized their promotion experience, which is important in terms of providing demonstration and valuable guidance for future work. The Group’s operation and management model was widely recognized by the Group Hospitals, and the “ten management tools (十大管理工具)” provided effective guidance for the practice of frontline management with evident results achieved. The operation of the Group Hospitals became more scientific and standardized, talents for various disciplines and technological construction were widely valued, and as a result, service quality significantly improved. The “Annual Business Plan 《年度商業計劃》 ( )” played a leading role in providing guidance, and the key tasks and construction projects of all units were implemented. The implementation of the Group’s resource sharing projects represented by the “Respiratory Medical Specialty (呼吸醫學專科)” jointly established by the regional medical center, Jinhua Hospital and Yongkang Hospital (with a technical team provided by the former to the latter), was strengthened. The Group started applied research of the disease diagnosis related group system (“DRGs”) with internal and external professional expertise (including the participation of well-known domestic experts), and established a database for data on diseases, which includes medical service efficiency, medical service capabilities, medical quality and safety, and cost-effectiveness of disease components. “DRGs” is used as a tool for lean management for providing data support for improving medical quality, strengthening the construction of disciplines, optimizing the constitution of types of diseases and reasonable cost control. With clearer principles and strategic positioning regarding investment and M&A, the integration of resources for investment projects with the Group being the leading entity and supported by multiple other parties was effected, and the Group’s investment decision-making standards and collectivized management model were formed. During the year under review, much work was accomplished with regard to collectivized management as a listed company and management and operation of the Group Hospitals. As a result, various lines of work, including the collectivized management and operation of the Group Hospitals, became more standardized and effective. Prospects: Based on the “Development Plan for Medium and Long-Term Construction (《中長期建設發展規劃》)” of the Group and under the proper leadership of the Board, the Group will build a firstclass value-creating medical group in China under the “Three Conforming (三符合)” conditions through comprehensive measures such as building “five strategic pillars (五個戰略支柱)” (i.e. (i) creating a value-creating corporate culture with advanced concepts and systems; (ii) integrating the resources of Legend Holdings, “Hony Capital” and listed companies to form a strong investment brand supported by outstanding operational results; (iii) possessing an income structure in relation to industrial synergies that can develop in a healthy, steady and fast manner, as well as a valuecreating efficient operation and management model that can be replicated quickly; (iv) establishing a branded multi-regional medical centre, “medical group (醫生集團)”, “internet hospital (互聯網醫院)” and centralized procurement center, and forming an innovative healthcare industry system with high synergies; and (v) planning the three-step development path of the “healthcare big data production, learning and research platform (大健康數據產學研平台)” to facilitate the integration of the digital economy and medical development, continuously gain insight into industry development opportunities and cross-industry integration, and build a complete and efficient healthcare industry ecosystem), and forming “five organizational guarantees (五個組織保障)” ((i) constructing a first-class high-quality investment and management integrated team at the group level to form a strong control over investments and operations; (ii) building a first-class management and technology team at the Group Hospital level to form strong core competencies; (iii) creating core advantages and strategic coordination in disciplines, hospitals and industry chain to form three major network systems; (iv) introducing eight major operational management systems to all acquired Group Hospitals to achieve a replicable management model; and (v) enhancing the integration of resources of Legend Holdings, “Hony Capital” and the capital markets to form the advantages in brand resources).

Information from the financial statements of listed companies

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.